Catalyst Wire Dossier Catalyst Wire Dossier

Kylo-12

Kylo-12 · Kylonova (Xiamen) Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kylo-12, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Single-ascending Dose Study of Kylo-12 in Healthy Subjects [Phase 1]

See pricing